KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

LifeMD (LFMD) EBT (2016 - 2025)

LifeMD filings provide 14 years of EBT readings, the most recent being -$6.0 million for Q4 2025.

  • On a quarterly basis, EBT rose 8.27% to -$6.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$9.0 million, a 63.42% increase, with the full-year FY2025 number at -$10.2 million, up 54.88% from a year prior.
  • EBT hit -$6.0 million in Q4 2025 for LifeMD, down from -$3.4 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $1.5 million in Q1 2025 to a low of -$18.0 million in Q4 2021.
  • Median EBT over the past 5 years was -$6.6 million (2024), compared with a mean of -$7.8 million.
  • Biggest five-year swings in EBT: crashed 393.98% in 2021 and later surged 123.01% in 2025.
  • LifeMD's EBT stood at -$18.0 million in 2021, then soared by 37.69% to -$11.2 million in 2022, then skyrocketed by 75.08% to -$2.8 million in 2023, then crashed by 135.36% to -$6.6 million in 2024, then grew by 8.27% to -$6.0 million in 2025.
  • The last three reported values for EBT were -$6.0 million (Q4 2025), -$3.4 million (Q3 2025), and -$1.1 million (Q2 2025) per Business Quant data.